Parkinson’s disease – media

Eye Movements Analysis for Parkinson’s Disease

A new robotic system called OSCANN Desk has been developed by researchers at Spain’s Universidad Politécnica de Madrid (UPM) and start-up AURA Innotive Robotics. The system has been designed for the accurate analysis of eye movements in order to detect neurodegenerative diseases such as Parkinson’s disease.
- Source: Verdict Medical Devices
- 670
- June 19, 2018
digital health machine learning New Approvals Parkinson’s disease
Michael J Fox Foundation launches project to gather information through wearable

With a view of gathering mHealth data through a wearable from over 800 people with Parkinson’s disease, a project has been unveiled by the Michael J Fox Foundation which has been doing pioneering work in Parkinson’s disease.
- Source: drugdu
- 505
- May 14, 2018
mHealth Parkinson’s disease Researches
App accurately tracks Parkinson’s disease symptoms

Capturing a patient’s experience outside the doctor’s office has been an ongoing struggle when it comes to treating Parkinson’s disease. But now a new smartphone app can now detect the severity of symptoms in patients with Parkinson’s disease remotely, according to a recent study published by JAMA.
- Source: MobiHealthNews
- 686
- April 11, 2018
mHealth Parkinson’s disease Researches
Parkinson’s gene initiates disease outside of the brain

Until very recently, Parkinson's had been thought a disease that starts in the brain, destroying motion centers and resulting in the tremors and loss of movement. New research published this week in the journal Brain, shows the most common Parkinson's gene mutation may change how immune cells react to generic infections like colds, which in turn trigger the inflammatory reaction in the brain that causes Parkinson's. The research offers a new understanding of Parkinson's disease.
- Source: sciencedaily
- 562
- April 2, 2018
immune cells Parkinson’s disease Researches
Prevail Therapeutics Announces $75 Million Series A Financing to Advance Gene Therapies for Patients with Parkinson’s and Other Neurodegenerative Diseases

Prevail Therapeutics, Inc. (Prevail), a biotechnology company developing gene therapies for patients with Parkinson’s disease and other neurodegenerative diseases, today announced a $75 million Series A financing.
- Source: silversteinfoundation.orgl
- 656
- March 13, 2018
financing gene Market Views Parkinson’s disease
XOC PHARMACEUTICALS ANNOUNCES $30 MILLION SERIES A FINANCING LED BY NEA

Company to move forward with novel therapies for migraine and Parkinson’s disease
- Source: xocpharma
- 543
- February 27, 2018
CNS migraine Parkinson’s disease Series
Tiny implant opens way to deliver drugs deep into the brain

Scientists have created a hair-thin implant that can drip medications deep into the brain by remote control and with pinpoint precision.
- Source: CT Post
- 551
- January 29, 2018
cancer medical device Parkinson’s disease Researches
Tiny Wireless Neurostimulator Small Enough for Injections

The team has unveiled a neural stimulator that is less than a cubic millimeter in size that can be placed directly where desired and that is powered using an external induction-based system.
- Source: medgadget
- 543
- December 13, 2017
Neurostimulators Parkinson’s disease
Carmot Enters a Multi-Year Drug Discovery Collaboration With Amgen

Carmot Therapeutics, (Berkeley, CA) announced that it has entered into a multi-year drug discovery collaboration and licensing agreement with Amgen (Thousand Oaks, CA). As part of the agreement, Carmot will apply its proprietary lead-identification technology, Chemotype Evolution, to discover and advance novel drug leads intended for the treatment of Parkinson’s disease and other selected disease areas.
- Source: Bestsellermagazine
- 532
- December 11, 2017
Amgen Market Views Parkinson’s disease
Synpromics Announces Collaboration with UCL to Develop Revolutionary Gene Therapy for Parkinson’s Disease

Synpromics Ltd is pleased to announce a new collaboration with UCL to generate a range of synthetic gene promoters for the central nervous system (CNS), to develop a gene therapy for Parkinson’s disease.
- Source: Businesswire
- 472
- November 30, 2017
CNS Market Views Parkinson’s disease

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.